Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma
HR070803(伊立替康脂质体)联合5-氟尿嘧啶、亚叶酸钙和奥沙利铂治疗未经治疗的晚期或转移性胰腺导管腺癌的I期临床试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04234-4
Xu, Qiang; Zhao, Xue; Wang, Xianze; Zhu, Ruizhe; Cheng, Yuejuan; Xia, Tao; Wu, Heshui; Tian, He; Sun, Yuping; Zhang, Mingjun; Gao, Chuntao; Fu, Deliang; Wu, Xiaojie; Zheng, Tongsen; Yin, Xiaoyu; Chen, Yili; Chen, Xiaobing; Li, Zhihua; Chen, Rufu; Yang, Xue; Wang, Huan; Wang, Quanren; Han, Xiaohong; Wu, Wenming